Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530
Last updated 2023-07-19
Summary
This research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them. The treatments for childhood cancers are intense and result in a high rate of symptoms which require support by healthcare providers. By reviewing patients' medical chart records, meeting in focus groups and in one-on-one interviews, healthcare providers may improve how clinical practice guidelines are used to support children undergoing cancer treatment.
Conditions
- Acute Lymphoblastic Leukemia
- B-Cell Non-Hodgkin Lymphoma
- Childhood Acute Myeloid Leukemia
- Childhood Burkitt Lymphoma
- Childhood Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Recurrent Childhood Acute Lymphoblastic Leukemia
Interventions
- OTHER
-
Informational Intervention
Participate in focus group
- OTHER
-
Interview
Undergo one-on-one interviews
- OTHER
-
Medical Chart Review
Review of medical chart
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
L. Lee Dupuis · Children's Oncology Group
Eligibility
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-21
- Primary Completion
- 2023-03-31
- Completion
- 2023-06-30
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2
-
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01231919 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
NCT00003783 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
NCT00006462 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00186875 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003735 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
NCT00096135 ·Status: COMPLETED ·Phase: NA
-
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002704 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005585 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
NCT00057811 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00002785 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00002744 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia
NCT00022737 ·Status: COMPLETED ·Phase: PHASE3
-
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
NCT02512926 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00049569 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002618 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
NCT00017368 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003423 ·Status: UNKNOWN ·Phase: PHASE3
-
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00024284 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
NCT00002691 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
NCT00137111 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT02303821 ·Status: COMPLETED ·Phase: PHASE1